29 Apr

Posted at 23:13h in COVID-19, Employee Benefits by . .
[wpseo_breadcrumb]

News Brief header In a joint statement, the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have recommended lifting a pause on the distribution of the Johnson & Johnson (J&J) COVID-19 vaccine.

On April 13, the agencies recommended a pause on the J&J one-dose vaccine after reports of six cases of a rare and severe type of blood clot in individuals following administration of the vaccine. Reports of adverse events following the use of the J&J vaccine suggested an increased risk of a rare adverse event called thrombosis with thrombocytopenia syndrome (TTS). Nearly all reports of this serious condition, which involves blood clots with low platelets, have been in adult women under the age of 50.

16 Apr

Posted at 17:30h in COVID-19, Risk Management by . .
[wpseo_breadcrumb]

News Brief header In a joint statement, the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have called for an immediate halt on the distribution of the Johnson & Johnson (J&J) COVID-19 vaccine.

The CDC’s Advisory Committee on Immunization Practices will meet on Wednesday, April 14, to further review these cases and assess their potential significance. Until that process is complete, the agencies are recommending a pause in the use of the J&J vaccine out of an abundance of caution.

05 Mar

Posted at 17:41h in COVID-19, Employee Benefits by . .

News Brief header The U.S. Food and Drug Administration (FDA) recently issued an Emergency Use Authorization (EUA) for Johnson & Johnson’s COVID-19 vaccine to be distributed in the United States for use by individuals 18 years of age and older.

This authorization follows a recommendation from the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) to issue a EUA for the vaccine, and confirms that Americans will have access to a third effective coronavirus vaccine that will allow states to increase distribution.

09 Sep

Posted at 18:19h in COVID-19, Employee Benefits White Papers, Risk Management by . .

Live Well, Work Well - September 2020

 

Choosing an Effective Hand Sanitizer

Hand hygiene is an important response to the COVID-19 pandemic. The Centers for Disease Control and Prevention (CDC) recommends washing hands with soap and water. If those aren’t available, using a hand sanitizer can help you avoid getting sick and spreading germs. Americans are having a hard time tracking hand sanitizer down; however, the CDC doesn’t recommend that people make their own product, as there’s a chance it could be ineffective or cause skin burns.

09 Sep

Posted at 17:33h in Risk Management White Papers by . .
 

OSHA Safety Cornerstone - Third Quarter 2020

OSHA Reveals Increase in Whistleblower Complaints in the Midst of COVID-19

As the COVID-19 pandemic continues on, employee health and safety remains a top priority. Specifically, a key topic of concern has been whether workers who reported potential violations (e.g., a lack of social distancing or inadequate personal protective equipment) are being properly protected from employer retaliation. Read More Button